Cardiac Device Sensor Modes for VAD Hemodynamic Optimization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical device systems for heart failure patients with ventricular assist devices (VADs) lack advanced monitoring and control capabilities to optimize hemodynamic and physiologic status, leading to suboptimal patient management and potential adverse effects.
Innovation Solution
A medical device system comprising a cardiac device with a processor, memory, communications circuit, and sensors, capable of engaging specific sensor modes for VAD patients, processing data, and adjusting operational parameters of both cardiac rhythm management devices and VADs to optimize patient status and minimize adverse effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current medical device systems are used for heart failure patients with VADs, then basic monitoring is provided, but advanced monitoring and control capabilities are lacking leading to suboptimal patient management
Solution Approach 1:
The patent combines multiple monitoring functions (hemodynamic monitoring, sensor data collection, device coordination) into a single integrated cardiac device system. The cardiac device receives and processes data from multiple sensors including pressure sensors, flow sensors, and other physiological sensors, consolidating what would otherwise require multiple separate devices into one unified system that can coordinate both CRM and VAD operations.
Solution Approach 2:
The cardiac device is designed with multi-functionality to serve multiple purposes: it monitors hemodynamic status, collects sensor data, communicates with both CRM and VAD devices, processes physiological data, and generates control instructions. This universal device replaces the need for multiple specialized devices, providing advanced monitoring capabilities while managing system complexity through consolidation.
2Power
If VADs provide mechanical circulatory support, then blood pumping assistance is achieved, but native LV pump function may deteriorate and vascular stiffening may occur
Solution Approach 1:
The system implements continuous feedback monitoring through multiple sensors that detect hemodynamic parameters such as pressure, flow, and other physiological indicators. The cardiac device processes this sensor data and generates instructions to adjust VAD operational parameters in real-time. This feedback mechanism allows the system to respond to changing patient conditions, optimizing blood pumping force while preventing harmful effects like vascular stiffening and maintaining native LV pump function.
Solution Approach 2:
The VAD operational parameters are made dynamic rather than fixed. The system continuously adjusts VAD settings based on real-time sensor data and patient physiological status. This dynamic adjustment allows the blood pumping force to adapt to changing conditions, providing sufficient power when needed while preventing over-pumping that could cause vascular stiffening or compromise myocardial perfusion.
3Loss of information
If cardiac devices monitor patient status, then basic data collection is achieved, but specific sensor modes for VAD patients are not engaged
Solution Approach 1:
The cardiac device is pre-configured with specific sensor modes designed for VAD patients. Rather than requiring complex real-time configuration, the system has predetermined sensor modes that are automatically engaged based on patient identification or system initialization. These pre-programmed modes ensure that the appropriate sensor data is collected from the outset, maintaining data quality while simplifying the configuration process.
Solution Approach 2:
The system utilizes parameter changes in sensor operation modes to optimize data collection for VAD patients. Different sensor modes with specific parameters are selected based on the patient's condition and device configuration. The cardiac device automatically adjusts sensor parameters such as sampling rates, thresholds, and measurement types to match the specific monitoring needs of VAD patients, ensuring high-quality data collection without manual complexity.
4Duration of action of stationary object
If VADs are used as destination therapy, then long-term support is provided, but lack of advanced control leads to potential adverse effects
Solution Approach 1:
For long-term destination therapy, the system implements continuous feedback monitoring through multiple sensors that track hemodynamic parameters, device performance, and patient physiological status over extended periods. The cardiac device processes this ongoing sensor data and generates real-time adjustments to VAD operational parameters. This sustained feedback mechanism ensures that the VAD continues to provide optimal blood pumping force while preventing adverse effects such as vascular stiffening, maintaining native LV function, and adapting to long-term physiological changes in the patient.
Solution Approach 2:
The system incorporates self-service capabilities where the cardiac device autonomously monitors patient status, processes sensor data, and adjusts VAD parameters without requiring constant external intervention. The device can independently detect adverse trends and make corrective adjustments to prevent harmful effects, providing self-managed long-term support that maintains safety and effectiveness over extended therapy durations.
Data Source
AI summary
The present document discusses medical device systems and related methods. In an embodiment, a medical device system can include a cardiac device. The cardiac device can include a processor, a memory, a communications circuit, and one or more sensors. The cardiac device can be configured to engage a sensor mode specific for patients receiving or having implanted ventricular assist devices. The cardiac device can be configured to process data as specified by the sensor mode specific for patients receiving or having implanted ventricular assist devices. In an embodiment, a method for monitoring heart failure patients is discussed. In an embodiment, a method of controlling devices for heart failure patients is discussed. Other embodiments are also included herein.